IBDEI0LN ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1349,0)
 ;;=BIOPSY^1^121
 ;;^UTILITY(U,$J,358.4,1350,0)
 ;;=TISSUE REARRANGEMENT-ANY AREA^38^121
 ;;^UTILITY(U,$J,358.4,1351,0)
 ;;=NEW PATIENT^2^122
 ;;^UTILITY(U,$J,358.4,1352,0)
 ;;=ESTABLISHED PATIENT^1^122
 ;;^UTILITY(U,$J,358.4,1353,0)
 ;;=CONSULTATION^3^122
 ;;^UTILITY(U,$J,358.4,1354,0)
 ;;=ALPHA ORDER (A)^2^123
 ;;^UTILITY(U,$J,358.4,1355,0)
 ;;=ALPHA ORDER (B)^3^123
 ;;^UTILITY(U,$J,358.4,1356,0)
 ;;=ALPHA ORDER (C)^4^123
 ;;^UTILITY(U,$J,358.4,1357,0)
 ;;=ALPHA ORDER (D)^5^123
 ;;^UTILITY(U,$J,358.4,1358,0)
 ;;=ALPHA ORDER (E)^6^123
 ;;^UTILITY(U,$J,358.4,1359,0)
 ;;=ALPHA ORDER (F)^7^123
 ;;^UTILITY(U,$J,358.4,1360,0)
 ;;=ALPHA ORDER (G)^8^123
 ;;^UTILITY(U,$J,358.4,1361,0)
 ;;=ALPHA ORDER (H)^9^123
 ;;^UTILITY(U,$J,358.4,1362,0)
 ;;=ALPHA ORDER (I)^10^123
 ;;^UTILITY(U,$J,358.4,1363,0)
 ;;=ALPHA ORDER (K)^11^123
 ;;^UTILITY(U,$J,358.4,1364,0)
 ;;=ALPHA ORDER (L)^12^123
 ;;^UTILITY(U,$J,358.4,1365,0)
 ;;=ALPHA ORDER (M)^13^123
 ;;^UTILITY(U,$J,358.4,1366,0)
 ;;=ALPHA ORDER (N)^14^123
 ;;^UTILITY(U,$J,358.4,1367,0)
 ;;=ALPHA ORDER (O)^15^123
 ;;^UTILITY(U,$J,358.4,1368,0)
 ;;=ALPHA ORDER (P)^16^123
 ;;^UTILITY(U,$J,358.4,1369,0)
 ;;=ALPHA ORDER (R)^17^123
 ;;^UTILITY(U,$J,358.4,1370,0)
 ;;=ALPHA ORDER (S)^18^123
 ;;^UTILITY(U,$J,358.4,1371,0)
 ;;=ALPHA ORDER (T)^19^123
 ;;^UTILITY(U,$J,358.4,1372,0)
 ;;=ALPHA ORDER (U)^20^123
 ;;^UTILITY(U,$J,358.4,1373,0)
 ;;=ALPHA ORDER (V)^21^123
 ;;^UTILITY(U,$J,358.4,1374,0)
 ;;=ALPHA ORDER (X)^22^123
 ;;^UTILITY(U,$J,358.4,1375,0)
 ;;=V CODES^23^123
 ;;^UTILITY(U,$J,358.4,1376,0)
 ;;=INCISION & DRAINAGE^10^124
 ;;^UTILITY(U,$J,358.4,1377,0)
 ;;=DEBRIDEMENT^5^124
 ;;^UTILITY(U,$J,358.4,1378,0)
 ;;=SHAVING EPIDERMAL/DERMAL LESIONS^24^124
 ;;^UTILITY(U,$J,358.4,1379,0)
 ;;=NAILS^14^124
 ;;^UTILITY(U,$J,358.4,1380,0)
 ;;=PARING OR CUTTING^19^124
 ;;^UTILITY(U,$J,358.4,1381,0)
 ;;=DESTRUCTION-BENIGN OR PREMALIGANT^6^124
 ;;^UTILITY(U,$J,358.4,1382,0)
 ;;=EXCISION-BENIGN LESION (EXCEPT SKIN TAG)^7^124
 ;;^UTILITY(U,$J,358.4,1383,0)
 ;;=EXCISION-MALIGNANT LESIONS^9^124
 ;;^UTILITY(U,$J,358.4,1384,0)
 ;;=REPAIR/CLOSURE^23^124
 ;;^UTILITY(U,$J,358.4,1385,0)
 ;;=BURNS^3^124
 ;;^UTILITY(U,$J,358.4,1386,0)
 ;;=OTHER SKIN PROCEDURES^18^124
 ;;^UTILITY(U,$J,358.4,1387,0)
 ;;=INJECTIONS^12^124
 ;;^UTILITY(U,$J,358.4,1388,0)
 ;;=INJECTION SUBSTANCE^13^124
 ;;^UTILITY(U,$J,358.4,1389,0)
 ;;=REPAIR, REVISE and/or RECONSTRUCT^22^124
 ;;^UTILITY(U,$J,358.4,1390,0)
 ;;=INCISION-FOOT/TOES^11^124
 ;;^UTILITY(U,$J,358.4,1391,0)
 ;;=EXCISION-FOOT/TOES^8^124
 ;;^UTILITY(U,$J,358.4,1392,0)
 ;;=OTHER PROCEDURES^17^124
 ;;^UTILITY(U,$J,358.4,1393,0)
 ;;=OPEN OR CLOSED TREATMENT OF FRACTURES^15^124
 ;;^UTILITY(U,$J,358.4,1394,0)
 ;;=ARTHRODESIS^2^124
 ;;^UTILITY(U,$J,358.4,1395,0)
 ;;=CASTS/SPLINTS/STRAPPING APPLICATION^4^124
 ;;^UTILITY(U,$J,358.4,1396,0)
 ;;=REMOVAL/REPAIR OF CASTS^21^124
 ;;^UTILITY(U,$J,358.4,1397,0)
 ;;=OTHER ORTHOTICS^16^124
 ;;^UTILITY(U,$J,358.4,1398,0)
 ;;=SUPPLIES^25^124
 ;;^UTILITY(U,$J,358.4,1399,0)
 ;;=REMOVAL^20^124
 ;;^UTILITY(U,$J,358.4,1400,0)
 ;;=AMPUTATION^1^124
 ;;^UTILITY(U,$J,358.4,1401,0)
 ;;=GRAFT^10^124
 ;;^UTILITY(U,$J,358.4,1402,0)
 ;;=NEW PATIENT^2^125
 ;;^UTILITY(U,$J,358.4,1403,0)
 ;;=ESTABLISHED PATIENT^1^125
 ;;^UTILITY(U,$J,358.4,1404,0)
 ;;=IMMUNIZATION^6^126
 ;;^UTILITY(U,$J,358.4,1405,0)
 ;;=INJECTION^7^126
 ;;^UTILITY(U,$J,358.4,1406,0)
 ;;=SKIN TEST^15^126
 ;;^UTILITY(U,$J,358.4,1407,0)
 ;;=NURSING PROCEDURES^9^126
 ;;^UTILITY(U,$J,358.4,1408,0)
 ;;=MINOR PROCEDURES^8^126
 ;;^UTILITY(U,$J,358.4,1409,0)
 ;;=SPLINTS^16^126
 ;;^UTILITY(U,$J,358.4,1410,0)
 ;;=EDUCATION/TRAINING^3^126
 ;;^UTILITY(U,$J,358.4,1411,0)
 ;;=ALLERGY SHOTS^1^126
 ;;^UTILITY(U,$J,358.4,1412,0)
 ;;=EKG^4^126
 ;;^UTILITY(U,$J,358.4,1413,0)
 ;;=BEHAVIORAL CHANGE INTERVENTION^2^126
 ;;^UTILITY(U,$J,358.4,1414,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^10^126
 ;;^UTILITY(U,$J,358.4,1415,0)
 ;;=GYN PROCEDURES^5^126
 ;;^UTILITY(U,$J,358.4,1416,0)
 ;;=PREVENTIVE MED-EST PT^12^126
 ;;^UTILITY(U,$J,358.4,1417,0)
 ;;=PREVENTIVE MED-NEW PT^13^126
 ;;^UTILITY(U,$J,358.4,1418,0)
 ;;=RISK FACTOR REDUCTION^14^126
 ;;^UTILITY(U,$J,358.4,1419,0)
 ;;=PREVENTIVE GROUP COUNSELING^11^126
 ;;^UTILITY(U,$J,358.4,1420,0)
 ;;=CARDIOVASCULAR^3^127
 ;;^UTILITY(U,$J,358.4,1421,0)
 ;;=ENDOCRINE/METABOLIC^7^127
 ;;^UTILITY(U,$J,358.4,1422,0)
 ;;=PULMONARY^22^127
 ;;^UTILITY(U,$J,358.4,1423,0)
 ;;=EENT^6^127
 ;;^UTILITY(U,$J,358.4,1424,0)
 ;;=MUSCULOSKELETAL^17^127
 ;;^UTILITY(U,$J,358.4,1425,0)
 ;;=NEURO^18^127
 ;;^UTILITY(U,$J,358.4,1426,0)
 ;;=MENTAL HEALTH^16^127
 ;;^UTILITY(U,$J,358.4,1427,0)
 ;;=GASTROENTEROLOGY^8^127
 ;;^UTILITY(U,$J,358.4,1428,0)
 ;;=GU/RENAL^9^127
 ;;^UTILITY(U,$J,358.4,1429,0)
 ;;=WOMEN'S HEALTH^25^127
 ;;^UTILITY(U,$J,358.4,1430,0)
 ;;=HEMATOLOGY/ONCOLOGY^10^127
 ;;^UTILITY(U,$J,358.4,1431,0)
 ;;=INFECTIOUS DISEASE^12^127
 ;;^UTILITY(U,$J,358.4,1432,0)
 ;;=DERMATOLOGY^5^127
 ;;^UTILITY(U,$J,358.4,1433,0)
 ;;=HISTORY OF ILLNESS^11^127
 ;;^UTILITY(U,$J,358.4,1434,0)
 ;;=INJURY/TRAUMA^13^127
 ;;^UTILITY(U,$J,358.4,1435,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^24^127
 ;;^UTILITY(U,$J,358.4,1436,0)
 ;;=SEXUAL TRAUMA^23^127
 ;;^UTILITY(U,$J,358.4,1437,0)
 ;;=PAIN^20^127
 ;;^UTILITY(U,$J,358.4,1438,0)
 ;;=OTHER REASONS^19^127
 ;;^UTILITY(U,$J,358.4,1439,0)
 ;;=COMMON DIAGNOSES^2^127
 ;;^UTILITY(U,$J,358.4,1440,0)
 ;;=PREVENTIVE MEDICINE CODES^21^127
 ;;^UTILITY(U,$J,358.4,1441,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^127
 ;;^UTILITY(U,$J,358.4,1442,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^4^127
 ;;^UTILITY(U,$J,358.4,1443,0)
 ;;=MAJOR DEPRESSION^15^127
 ;;^UTILITY(U,$J,358.4,1444,0)
 ;;=LEGAL BLINDNESS^14^127
 ;;^UTILITY(U,$J,358.4,1445,0)
 ;;=BLOODS, ARTERIAL & VENOUS^1^128
 ;;^UTILITY(U,$J,358.4,1446,0)
 ;;=OXIMETRY (WHEN ONLY SERVICE)^6^128
 ;;^UTILITY(U,$J,358.4,1447,0)
 ;;=PULMONARY FUNCTION TESTING^7^128
 ;;^UTILITY(U,$J,358.4,1448,0)
 ;;=THORACENTESIS^9^128
 ;;^UTILITY(U,$J,358.4,1449,0)
 ;;=RESPIRATORY THERAPY^8^128
 ;;^UTILITY(U,$J,358.4,1450,0)
 ;;=BRONCHOSCOPY^2^128
 ;;^UTILITY(U,$J,358.4,1451,0)
 ;;=EXERCISE TESTING^3^128
 ;;^UTILITY(U,$J,358.4,1452,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^128
 ;;^UTILITY(U,$J,358.4,1453,0)
 ;;=IMMUNIZATIONS^5^128
 ;;^UTILITY(U,$J,358.4,1454,0)
 ;;=NEW PATIENT^2^129
 ;;^UTILITY(U,$J,358.4,1455,0)
 ;;=ESTABLISHED PATIENT^1^129
 ;;^UTILITY(U,$J,358.4,1456,0)
 ;;=CONSULTATIONS^3^129
 ;;^UTILITY(U,$J,358.4,1457,0)
 ;;=SIGNS & SYMPTOMS^1^130
 ;;^UTILITY(U,$J,358.4,1458,0)
 ;;=ENDOCRINE & METABOLIC^5^130
 ;;^UTILITY(U,$J,358.4,1459,0)
 ;;=HEMATOLOGIC & LYMPHATIC^9^130
 ;;^UTILITY(U,$J,358.4,1460,0)
 ;;=EYES, EARS & NOSE^6^130
 ;;^UTILITY(U,$J,358.4,1461,0)
 ;;=VASCULAR^25^130
 ;;^UTILITY(U,$J,358.4,1462,0)
 ;;=MUSCULOSKELETAL^13^130
 ;;^UTILITY(U,$J,358.4,1463,0)
 ;;=GENITOURINARY & RENAL^8^130
 ;;^UTILITY(U,$J,358.4,1464,0)
 ;;=CARDIAC^3^130
 ;;^UTILITY(U,$J,358.4,1465,0)
 ;;=INTERSTITIAL LUNG DISEASES^12^130
 ;;^UTILITY(U,$J,358.4,1466,0)
 ;;=OCCUPATIONAL^16^130
 ;;^UTILITY(U,$J,358.4,1467,0)
 ;;=OTHER^17^130
 ;;^UTILITY(U,$J,358.4,1468,0)
 ;;=PLEURAL DISEASE^19^130
 ;;^UTILITY(U,$J,358.4,1469,0)
 ;;=INFECTIOUS DISEASES^11^130
 ;;^UTILITY(U,$J,358.4,1470,0)
 ;;=NEUROMUSCULAR/SKELETAL^15^130
 ;;^UTILITY(U,$J,358.4,1471,0)
 ;;=GASTROINTESTINAL^7^130
 ;;^UTILITY(U,$J,358.4,1472,0)
 ;;=HEPATIC & BILIARY^22^130
 ;;^UTILITY(U,$J,358.4,1473,0)
 ;;=NEUROLOGIC^14^130
 ;;^UTILITY(U,$J,358.4,1474,0)
 ;;=SKIN^28^130
 ;;^UTILITY(U,$J,358.4,1475,0)
 ;;=PSYCHIATRIC & BEHAVIORAL^20^130
 ;;^UTILITY(U,$J,358.4,1476,0)
 ;;=CANCER^2^130
 ;;^UTILITY(U,$J,358.4,1477,0)
 ;;=RADIATION^21^130
 ;;^UTILITY(U,$J,358.4,1478,0)
 ;;=SKELETAL^22^130
 ;;^UTILITY(U,$J,358.4,1479,0)
 ;;=PAIN^18^130
 ;;^UTILITY(U,$J,358.4,1480,0)
 ;;=SUTURES/DRESSINGS^24^130
 ;;^UTILITY(U,$J,358.4,1481,0)
 ;;=COMPLICATIONS^4^130
 ;;^UTILITY(U,$J,358.4,1482,0)
 ;;=ESOPHAGUS^4^131
 ;;^UTILITY(U,$J,358.4,1483,0)
 ;;=LYMPH NODES (SECONDARY)^6.5^131
 ;;^UTILITY(U,$J,358.4,1484,0)
 ;;=LARYNX^6.4^131
 ;;^UTILITY(U,$J,358.4,1485,0)
 ;;=LUNG^6.41^131
 ;;^UTILITY(U,$J,358.4,1486,0)
 ;;=MELANOMA^6.6^131
 ;;^UTILITY(U,$J,358.4,1487,0)
 ;;=GENITOURINARY^.5^131
 ;;^UTILITY(U,$J,358.4,1488,0)
 ;;=BRAIN^.7^131
 ;;^UTILITY(U,$J,358.4,1489,0)
 ;;=BREAST-FEMALE^.6^131
 ;;^UTILITY(U,$J,358.4,1490,0)
 ;;=HYPOPHARYNX^6.1^131
 ;;^UTILITY(U,$J,358.4,1491,0)
 ;;=CONNECTIVE & SOFT TISSUE^2^131
 ;;^UTILITY(U,$J,358.4,1492,0)
 ;;=RADIATION FOLLOW-UP^.45^131
 ;;^UTILITY(U,$J,358.4,1493,0)
 ;;=MOUTH^8^131
 ;;^UTILITY(U,$J,358.4,1494,0)
 ;;=MOUTH-FLOOR^9^131
 ;;^UTILITY(U,$J,358.4,1495,0)
 ;;=NASOPHARYNX^10^131
 ;;^UTILITY(U,$J,358.4,1496,0)
 ;;=OROPHARYNX^11^131
 ;;^UTILITY(U,$J,358.4,1497,0)
 ;;=PANCREAS^12^131
 ;;^UTILITY(U,$J,358.4,1498,0)
 ;;=RECTUM/ANUS^13^131
 ;;^UTILITY(U,$J,358.4,1499,0)
 ;;=SALIVARY GLANDS^14^131
 ;;^UTILITY(U,$J,358.4,1500,0)
 ;;=SECONDARY MALIGNANT NEOPLASMS^15^131
 ;;^UTILITY(U,$J,358.4,1501,0)
 ;;=TONGUE^16^131
 ;;^UTILITY(U,$J,358.4,1502,0)
 ;;=MISCELLANEOUS^18^131
 ;;^UTILITY(U,$J,358.4,1503,0)
 ;;=BENIGN NEOPLASMS^.47^131
 ;;^UTILITY(U,$J,358.4,1504,0)
 ;;=RADIATION TREATMENT^.2^131
 ;;^UTILITY(U,$J,358.4,1505,0)
 ;;=PERSONAL HISTORY CA^19^131
 ;;^UTILITY(U,$J,358.4,1506,0)
 ;;=FOLLOW-UP^2^132
 ;;^UTILITY(U,$J,358.4,1507,0)
 ;;=CONSULTATIONS^1^132
 ;;^UTILITY(U,$J,358.4,1508,0)
 ;;=NURSING^4^132
 ;;^UTILITY(U,$J,358.4,1509,0)
 ;;=NEW PATIENT^3^132
 ;;^UTILITY(U,$J,358.4,1510,0)
 ;;=TREATMENT PLANNING^10^133
 ;;^UTILITY(U,$J,358.4,1511,0)
 ;;=SIMULATION^5^133
 ;;^UTILITY(U,$J,358.4,1512,0)
 ;;=TREATMENT DEVICES^9^133
 ;;^UTILITY(U,$J,358.4,1513,0)
 ;;=DOSIMETRY CALCULATIONS^2^133
 ;;^UTILITY(U,$J,358.4,1514,0)
 ;;=TELETHERAPY ISODOSE PLAN^7^133
 ;;^UTILITY(U,$J,358.4,1515,0)
 ;;=WEEKLY TX MANAGEMENT^11^133
 ;;^UTILITY(U,$J,358.4,1516,0)
 ;;=MISCELLANEOUS^4^133
